Skip to main content
logo
Guardant Health, Inc. (BMV:GH)
Mexico flag Mexico · Delayed Price · Currency is MXN
820.00
-23.00 (-2.73%)
At close: May 12, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 2014 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2019
Precision Oncology Testing
Log In
Log In
Log In
Log In
Upgrade
Precision Oncology Testing Growth
Log In
Log In
Log In
Log In
Upgrade
Development Services and Other
Log In
Log In
Log In
Log In
Upgrade
Development Services and Other Growth
Log In
Log In
Log In
Log In
Upgrade

Gross Income by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 2014 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2019
Precision Oncology Testing Gross Profit
Log In
Log In
Log In
Log In
Upgrade
Precision Oncology Testing Gross Profit Growth
Log In
Log In
Log In
Log In
Upgrade
Development Services and Other Gross Profit
Log In
Log In
Log In
Log In
Upgrade
Development Services and Other Gross Profit Growth
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2015 - 2020
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2015 - 2020
United States
733.42M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
29.82%
Log In
Log In
Log In
Log In
Upgrade
International
40.57M
Log In
Log In
Log In
Log In
Upgrade
International Growth
4.67%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2015 - 2020
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2015 - 2020
Clinical Test Sales Volume
218.80K
Log In
Log In
Log In
Log In
Upgrade
Clinical Test Sales Volume Growth
25.80%
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Test Sales Volume
-
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Test Sales Volume Growth
-
Log In
Log In
Log In
Log In
Upgrade